No abstract available
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Ascitic Fluid / diagnostic imaging*
-
Ascitic Fluid / pathology*
-
Ascitic Fluid / therapy
-
Biomarkers, Tumor / analysis
-
CA-125 Antigen / analysis
-
CA-19-9 Antigen / analysis
-
Carcinoembryonic Antigen / analysis
-
Combined Modality Therapy
-
Female
-
Follow-Up Studies
-
Humans
-
Middle Aged
-
Peritoneal Neoplasms / diagnosis*
-
Peritoneal Neoplasms / therapy
-
Peritoneum / surgery
-
Pseudomyxoma Peritonei / diagnosis*
-
Pseudomyxoma Peritonei / therapy
-
Treatment Outcome
-
Ultrasonography
Substances
-
Biomarkers, Tumor
-
CA-125 Antigen
-
CA-19-9 Antigen
-
Carcinoembryonic Antigen